|
|
Board of Directors
Officers
| Chair |
|
Thomas F. Taylor, Roush
Life Sciences |
| First Vice-Chair |
|
Richard G. Ganz |
| Second Vice-Chair |
|
Jay Caplan, Candela Corporation
|
| Treasurer |
|
Jed Hall, Brown Brothers Harriman
& Company |
| Secretary |
|
Mary Feely Moriarty, Korn/Ferry
International |
| Immediate Past Chairman |
|
Doug Lawrence, BD Medical-Ophthalmic
Systems |
Directors
David Cavanaugh, Wilmer Cutler
Pickering Hale and Dorr, LLP
Andrew Diston, Cambridge
Consultants
Paul Donovan, Boston Scientific
Corporation
David Dykeman, Greenberg Traurig LLP
Michael A. Hickey, K&L
Gates LLP
Jason Honeyman, Wolf
Greenfield & Sacks, PC
Brian Jarvis, BIT Group
Mordecai Kramer, Harvard
Clinical Research Institute, Inc.
Lisa Lopez, Haemonetics
Corporation
Joseph Metzger, Smith
& Nephew Endoscopy
Rich Miller, Manta Product Development,
Inc.
Thomas J. Moore, MD, Boston
University Medical Center
Gerard Moufflet, Kika Medical
Mary Murray, Ph.D., Hamilton, Brook,
Smith & Reynolds, P.C.
Mike W. O'Hara, Deloitte &
Touche LLP
Marie O'Malley, Medtronic Corporation
Maggie Pax, MicroCHIPS
Leslie Steiner, Philips
Healthcare
Tom Umbel Hologic, Inc.
Ray Zemlin, Goodwin Procter
LLP
Regulatory Advisor to the Board
Pam Weagraff, T2 Biosystems,
Inc.
Directors Emeritus
David D. Fleming, Genzyme
Corporation
John Mazzola, Transmedics,
Inc.
Richard A. Packer, ZOLL
Medical Corp.
Josh Tolkoff, Ironwood
Equity Fund
John J. Wallace
MassMEDIC PRESIDENT
Thomas J. Sommer
|
|
|